Intensive blood pressure control may slow age-related brain damage

Washington, DC - In a nationwide study, researchers used magnetic resonance imaging (MRI) to scan the brains of hundreds of participants in the National Institutes of Health’s Systolic Blood Pressure Intervention Trial (SPRINT) and found that intensively controlling a person’s blood pressure was more effective at slowing the accumulation of white matter lesions than standard treatment of high blood pressure.

Enterovirus antibodies detected in acute flaccid myelitis patients

Washington, DC - A new study analyzing samples from patients with and without acute flaccid myelitis (AFM) provides additional evidence for an association between the rare but often serious condition that causes muscle weakness and paralysis, and infection with non-polio enteroviruses.

An Arizona Transplant Family is Celebrating National Minority Donor Awareness Week

Yuma, Arizona - August 1st - 7th is recognized as National Minority Donor Awareness Week, which was created in 1998 to increase our nation’s consciousness of the need for more organ and tissue donors -- especially among multicultural communities. National Minority Donor Awareness Week honors communities of color who have been donors, and encourages others to register as donors. It is about empowering multicultural communities to save and heal lives by registering as organ and tissue donors.

NIH-funded study will test seasonal flu vaccines with two experimental adjuvants

Washington, DC - An early-stage clinical trial is evaluating two licensed seasonal influenza vaccines, administered with or without novel adjuvants, for their safety and ability to generate an immune response. Adjuvants are compounds added to vaccines to induce stronger and longer-lasting immune responses. The Phase 1 study is enrolling healthy adult volunteers at eight sites across the United States.

American Diabetes Association® Applauds the Insulin Price Reduction Act

Washington, DC - The American Diabetes Association (ADA) strongly supports the introduction of the Insulin Price Reduction Act in the United States Senate. The ADA thanks Senate Diabetes Caucus Co-Chairs Senator Jeanne Shaheen (D-NH) and Senator Susan Collins (R-ME) as well as Senator Tom Carper (D-DE) and Senator Kevin Cramer (R-ND) for their leadership in introducing this legislation, which will lower the cost of insulin for many Americans who rely on insulin to stay alive.